Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Chronic immune barrier dysregulation among women with a history of violence victimization
Alison Swaims-Kohlmeier, Lisa B. Haddad, Zheng-Rong Tiger Li, Kathryn A. Brookmeyer, James M. Baker, Cathy Spatz Widom, James C. Lamousin, Kai-Hua Chi, Cheng Y. Chen, Ellen N. Kersh, Jeffrey A. Johnson, Melissa M. Herbst-Kralovetz, Matthew Hogben, Igho Ofotokun, Jacob E. Kohlmeier
Alison Swaims-Kohlmeier, Lisa B. Haddad, Zheng-Rong Tiger Li, Kathryn A. Brookmeyer, James M. Baker, Cathy Spatz Widom, James C. Lamousin, Kai-Hua Chi, Cheng Y. Chen, Ellen N. Kersh, Jeffrey A. Johnson, Melissa M. Herbst-Kralovetz, Matthew Hogben, Igho Ofotokun, Jacob E. Kohlmeier
View: Text | PDF
Research Article Immunology

Chronic immune barrier dysregulation among women with a history of violence victimization

  • Text
  • PDF
Abstract

We explored the association between violence victimization and increased risk for acquiring sexually transmitted infections (STIs) in women by measuring cellular immune barrier properties from the female reproductive tract. STI-negative participants reporting repeated prior victimization occurrences through the lifetime trauma and victimization history (LTVH) instrument were more likely to exhibit alterations in barrier homeostasis and the composition of critical immune mediators irrespective of demographic parameters or presence of bacterial vaginosis. By combining cellular data with mixed-effect linear modeling, we uncovered differences in local T cells, MHCII+ antigen–presenting cells, and epithelial cells indicative of altered trafficking behavior, increased immunosuppressive function, and decreased barrier integrity at sites of STI exposure that correlate most strongly with LTVH score. These data evidence a biological link between a history of violence victimization and risk of STI acquisition through immune dysregulation in the female reproductive tract.

Authors

Alison Swaims-Kohlmeier, Lisa B. Haddad, Zheng-Rong Tiger Li, Kathryn A. Brookmeyer, James M. Baker, Cathy Spatz Widom, James C. Lamousin, Kai-Hua Chi, Cheng Y. Chen, Ellen N. Kersh, Jeffrey A. Johnson, Melissa M. Herbst-Kralovetz, Matthew Hogben, Igho Ofotokun, Jacob E. Kohlmeier

×

Figure 2

Prior trauma and victimization experiences reported are associated with phenotypic deviations of critical cellular immune mediators at the FRT barrier.

Options: View larger image (or click on image) Download as PowerPoint
Prior trauma and victimization experiences reported are associated with ...
(A) Cell numbers from participant samples (n = 66) with low (gray box and whiskers) compared with high LTVH event scores (white box and whiskers) (box depicting the interquartile range with median bar and whiskers depicting minimum and maximum values). (B) Representative flow plots (left) depicting APC gating from viable leukocytes from FRT (top) and matched PBMCs (bottom). Histograms illustrating CD103, CCR5, and CCR7 expression measurement from APCs (labeled center); FRT samples (red overlay) are compared with matched PBMCs (gray overlay). Frequency of chemokine receptor or integrin APC expression (n = 55) from high- (white box and whiskers) and low-scoring (gray box and whiskers) participant samples (right) (box depicting the interquartile range with median bar and whiskers depicting minimum and maximum values). (C) Quantitative reverse transcription PCR heatmap depicting fold change in epithelial gene transcript measurement from high- compared with low-scoring participant samples. (D) Representative gating strategy for T cell characterization (top). Viable T cells (n = 54) are distinguished for CD4 and CD8 expression. CCR7, CD69, and CD103 expression frequency of CD4+ and CD8+ T cells from high-scoring (white-circle background box and whiskers) and low-scoring (black-circle background gray box and whiskers) samples (box depicting the interquartile range with median bar and whiskers depicting minimum and maximum values) (bottom left). Boolean analysis of CCR7, CD69, and CD103 coexpression frequency from CD4+ and CD8+ T cells (bottom right). Significance calculated by an unpaired, 2-tailed Student’s t test. **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts